SP5M-001

N/A

Report date: 2025/09/01 17:45:36

Base Information

Drug NameSP5M-001

Drug Alias NameHMDA cross-linked hyaluronate intra-articular injectionHexamethylenediamine cross-linked hyaluronate intra-articular injectionSP5M001SP5M-001

ClassificationSmall molecules > Carbohydrate

Mechanisms of ActionHyaluronic acid modulators

TargetsHyaluronic acid

Therapy Area/IndicationsOsteoarthritis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaN/A

Originator CompaniesShin Poong Pharmaceutical Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesShin Poong Pharmaceutical Co Ltd

Inactive CompaniesN/A

Active IndicationsOsteoarthritis

Inactive IndicationsN/A

Other Information

ATC CodeN/A